HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haematological and lymphocyte subset analyses in sheep inoculated with bovine immunodeficiency-like virus.

Abstract
Bovine immunodeficiency-like virus (BIV) was passaged in vivo by intraperitoneal transfusion of ovine whole blood. Prior to transfusion, the recipient sheep were given sodium thioglycolate intraperitoneally to induce mild non-suppurative inflammation. The anti-BIV antibody response, haematology, and peripheral blood lymphocyte subsets (B, gamma delta, CD2+, CD4+ and CD8+) of recipient sheep were assessed for one year following transfusion. Passaging was successful since serum anti-BIV antibody responses were detected in 5 of the 6 recipient sheep; 1 of the 5 remained seropositive throughout the study. Lentivirus was not isolated from the recipient sheep, but provirus was detected by the polymerase chain reaction in DNA from peripheral blood leukocytes in 3 of the 5 sheep that seroconverted. In the BIV-inoculated sheep, neutrophils and eosinophils were significantly increased (p < or = 0.05) at 3 months and between 6 and 8 months postinoculation, respectively. B, CD2+ and CD4+ cells and the CD4+/CD8+ ratios were significantly increased (p < or = 0.05) 2 months postinoculation. Mild, transient haematological changes occurred in BIV-exposed sheep, but illness was not detected in the year.
AuthorsR M Jacobs, H E Smith, C A Whetstone, D L Suarez, B Jefferson, V E Valli
JournalVeterinary research communications (Vet Res Commun) Vol. 18 Issue 6 Pg. 471-82 ( 1994) ISSN: 0165-7380 [Print] Netherlands
PMID7701785 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Animals
  • Antibodies, Viral (blood)
  • Blotting, Western
  • Immunodeficiency Virus, Bovine (immunology)
  • Lentivirus Infections (immunology, veterinary, virology)
  • Leukocyte Count (veterinary)
  • Lymphocyte Subsets
  • Sheep
  • Sheep Diseases (immunology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: